These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 15221987)

  • 1. Pediatric gastrointestinal stromal tumors and leiomyosarcoma.
    Cypriano MS; Jenkins JJ; Pappo AS; Rao BN; Daw NC
    Cancer; 2004 Jul; 101(1):39-50. PubMed ID: 15221987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
    Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
    Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
    Can B; Sökmensüer C
    Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
    Miettinen M; Sobin LH; Sarlomo-Rikala M
    Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
    Miettinen M; Lasota J
    Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal stromal tumors (GISTs) on prostate needle biopsy: A clinicopathologic study of 8 cases.
    Herawi M; Montgomery EA; Epstein JI
    Am J Surg Pathol; 2006 Nov; 30(11):1389-95. PubMed ID: 17063078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.
    Miettinen M; Furlong M; Sarlomo-Rikala M; Burke A; Sobin LH; Lasota J
    Am J Surg Pathol; 2001 Sep; 25(9):1121-33. PubMed ID: 11688571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas.
    Miettinen M; Sarlomo-Rikala M; Sobin LH; Lasota J
    Am J Surg Pathol; 2000 Feb; 24(2):211-22. PubMed ID: 10680889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revision of gastrointestinal mesenchymal tumors.
    Sornmayura P; Howannapakorn J; Karnsombut P
    J Med Assoc Thai; 2009 Jan; 92(1):87-95. PubMed ID: 19260248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
    Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
    Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological features of gastric stromal tumors.
    Nishida T; Nakamura J; Taniguchi M; Hirota S; Ito T; Kitamura Y; Matsuda H
    J Exp Clin Cancer Res; 2000 Dec; 19(4):417-25. PubMed ID: 11277317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
    Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
    Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract.
    Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A
    Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. True smooth muscle tumors of the small intestine: a clinicopathologic, immunhistochemical, and molecular genetic study of 25 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Mar; 33(3):430-6. PubMed ID: 18971781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric GISTs. Personal experience.
    Mingolla GP; Riccio PA; Linguerri R; La Donna M; Zannelli M; Artuso S
    Ann Ital Chir; 2007; 78(4):283-8; discussion 288-9. PubMed ID: 17990602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differential diagnosis and treatment of esophageal stromal tumors and smooth muscle tumors].
    Zhang X; Rong TH; Wu QL; Fu JH; Long H; Zhang LJ; Ma GW; Su XD; Li XD; Wang DF; Hu Y; Yang H
    Ai Zheng; 2006 Jul; 25(7):901-5. PubMed ID: 16831287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection.
    Rutkowski P; Wozniak A; Dębiec-Rychter M; Kąkol M; Dziewirski W; Zdzienicki M; Ptaszynski K; Jurkowska M; Limon J; Siedlecki JA
    Cancer; 2011 Nov; 117(21):4916-24. PubMed ID: 21456019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
    Lasota J; Dansonka-Mieszkowska A; Stachura T; Schneider-Stock R; Kallajoki M; Steigen SE; Sarlomo-Rikala M; Boltze C; Kordek R; Roessner A; Stachura J; Miettinen M
    Mod Pathol; 2003 Dec; 16(12):1257-64. PubMed ID: 14681327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.